Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Public Health and Surveillance

Date Submitted: Nov 19, 2026
Open Peer Review Period: Nov 19, 2026 - Jan 14, 2027
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Viral Load Levels Among Newly Reported Acute HIV Infections in Shenzhen, 2018–2025

  • Yifan Zhong; 
  • Jin Zhao; 
  • Lan Wei; 
  • Hao Li; 
  • Xiaohui Wang; 
  • Guilian Li; 
  • Yongxia Gan; 
  • Chenli Zheng; 
  • Yan Zhang; 
  • Yifan Cai; 
  • Zhihao Lin

ABSTRACT

Background:

Early detection and diagnosis of early and acute HIV infection have remained core goals of HIV diagnosis and treatment in recent years, as they are vital to lowering transmission risk and improving patient prognosis. HIV viral load and CD4+ T-lymphocyte counts serve as key laboratory markers to assess disease progression and clinical staging among people living with HIV.

Objective:

We aimed to analyze the epidemiological profiles and characteristics of newly reported acute HIV cases in Shenzhen (2018–2025), using data on viral load, CD4+ T-lymphocyte counts and HIV recent-infection avidity assays.

Methods:

We collected HIV-1 nucleic acid testing (viral load detection) and CD4+ T-lymphocyte count data from samples with negative or indeterminate HIV antibody confirmatory results between April 2018 and December 2025. We analyzed the distribution of viral load levels and performed correlation analyses using SPSS. Result: A total of 6588 samples were tested by HIV‑1 nucleic acid assay. Of these, 729 (11.07%) were initially nucleic acid‑positive, with viral loads ranging from 1.43 to 8.84 log10 copies/mL and a mean value of 7.41 log10 copies/mL. CD4+ T‑lymphocyte counts ranged from 0.26 to 1768 cells/μL, with a median of 255 cells/μL. There was a significant negative correlation between HIV‑1 viral load and CD4+ T‑lymphocyte counts (r = -0.291, P < 0.01). Combined with HIV‑1 avidity testing results, some individuals were identified as having acute‑phase infection and were therefore excluded from late HIV presentation cases. Conclusion: Among newly reported HIV-infected individuals in Shenzhen, those with acute infection generally had higher viral load levels and lower CD4⁺ T‑lymphocyte counts. Most patients with low CD4⁺ T‑lymphocyte counts would be misclassified as late presenters if classified solely by CD4⁺ T‑lymphocyte thresholds (< 350 cells/μL or < 200 cells/μL) set by domestic and international expert consensus. Additional testing strategies are required to differentiate late HIV presentation from acute infection. These efforts can improve the accuracy of prevention and control measures, facilitate stratified interventions and targeted treatment for patients across various infection stages, and enable reliable estimation of the regional prevalence of late HIV presentation.


 Citation

Please cite as:

Zhong Y, Zhao J, Wei L, Li H, Wang X, Li G, Gan Y, Zheng C, Zhang Y, Cai Y, Lin Z

Viral Load Levels Among Newly Reported Acute HIV Infections in Shenzhen, 2018–2025

JMIR Preprints. 19/11/2026:117302

DOI: 10.2196/preprints.117302

URL: https://preprints.jmir.org/preprint/117302

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.